KP Tissue Inc. Reports Robust Q2 2024 Performance
KP Tissue Inc. sees 18.6% EBITDA rise in Q2 2024, driven by sales gains and pricing strategy.
- Latest
- Trending
KP Tissue Inc. sees 18.6% EBITDA rise in Q2 2024, driven by sales gains and pricing strategy.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.